A U.S. Food and Drug Administration advisory panel voted Wednesday to recommend approval of Grail's Galleri blood test, which screens for more than 50 types of cancer from a single blood sample. Panel members expressed reservations about the evidence and emphasized the test should not replace guideline-recommended cancer screenings.
Chinese AI startup Manus will return to operating independently after Beijing blocked Meta Platforms' $2 billion acquisition of the company, forcing the tech giant to unwind the landmark deal. The collapse highlights regulatory risks facing Chinese entrepreneurs expanding globally.
Chinese AI startup Manus will return to operating independently after Beijing blocked Meta Platforms' $2 billion acquisition of the company, forcing the tech giant to unwind the landmark deal. The blocked takeover highlights regulatory risks facing Chinese entrepreneurs expanding globally.
